Boardroom Alpha
8-K primary document
ENGN · Current Report (Form 8-K) · Filed April 9, 2026

Engene Therapeutics Inc8-K exhibit

engn-ex3_1.htm
EX-3.1

 

Date and Time: April 6, 2026 03:13 PM Pacific Time Exhibit 3.1

 

img197432392_0.jpg

 

Mailing Address:

PO Box 9431 Stn Prov Govt

Victoria BC V8W 9V3

www.corporateonline.gov.bc.ca

Location:

2nd Floor - 940 Blanshard Street

Victoria BC

1 877 526-1526

 

Notice of Alteration

FORM 11

BUSINESS CORPORATIONS ACT

Section 257

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Filed Date and Time:

April 6, 2026 03:13 PM Pacific Time

 

 

 

 

NOTE:

Filed but not Effective - The Notice of Alteration may be withdrawn at any time prior to the specified date and time of alteration.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NOTICE OF ALTERATION

 

Incorporation Number:

Name of Company:

C1447134

ENGENE HOLDINGS INC.

 

 

Name Reservation Number:

Name Reserved:

NR0984968

ENGENE THERAPEUTICS INC.

 

 

 

 

 

 

ALTERATION EFFECTIVE DATE:

 

Specified Date and Time of Alteration: April 8, 2026 12:01 AM Pacific Time

 

 

 

 

 

 

CHANGE OF NAME OF COMPANY

 

From:

ENGENE HOLDINGS INC.

To:

ENGENE THERAPEUTICS INC.

 

Page 1 of 1


 

 

 

 

 

img197432392_0.jpg

Mailing Address:

PO Box 9431 Stn Prov Govt

Victoria BC V8W 9V3

www.corporateonline.gov.bc.ca

Location:

2nd Floor - 940 Blanshard Street

Victoria BC

1 877 526-1526

 

 

 

Cover Sheet

ENGENE THERAPEUTICS INC.

 

Confirmation of Service

 

Form Filed:

Notice of Alteration

Date and Time of Filing:

April 6, 2026 03:13 PM Pacific Time

Alteration Effective Date:

Specified Date and Time of Alteration: April 8, 2026 12:01 AM

Pacific Time

Name of Company:

ENGENE THERAPEUTICS INC.

Incorporation Number:

C1447134

 

 

 

This package contains:

Certified Copy of the Notice of Articles
Certificate of Name Change

 

 

 

Check your documents carefully to ensure there are no errors or omissions. If errors or omissions are discovered, please contact the Corporate Registry for instructions on how to correct the errors or omissions.

 

Page 1 of 1


 

 

img197432392_0.jpg

 

Mailing Address:

PO Box 9431 Stn Prov Govt

Victoria BC V8W 9V3

www.corporateonline.gov.bc.ca

Location:

2nd Floor - 940 Blanshard Street

Victoria BC

1 877 526-1526

 

 

 

 

CERTIFIED COPY

Of a Document filed with the Province of British Columbia Registrar of Companies

 

Notice of Articles

BUSINESS CORPORATIONS ACT

img197432392_1.jpg

KERRY TAYLOR

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This Notice of Articles was issued by the Registrar on: April 8, 2026 12:01 AM Pacific Time

 

 

 

 

Incorporation Number:

C1447134

 

 

 

 

Recognition Date and Time: Continued into British Columbia on October 31, 2023 12:07 AM Pacific Time

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NOTICE OF ARTICLES

 

Name of Company:

 

ENGENE THERAPEUTICS INC.

 

 

 

 

 

REGISTERED OFFICE INFORMATION

 

 

Mailing Address:

1133 MELVILLE STREET

SUITE 3500 THE STACK

VANCOUVER BC V6E 4E5

CANADA

 

Delivery Address:

1133 MELVILLE STREET

SUITE 3500 THE STACK

VANCOUVER BC V6E 4E5

CANADA

 

 

 

RECORDS OFFICE INFORMATION

 

 

Mailing Address:

1133 MELVILLE STREET

SUITE 3500 THE STACK

VANCOUVER BC V6E 4E5

CANADA

Delivery Address:

1133 MELVILLE STREET

SUITE 3500 THE STACK

VANCOUVER BC V6E 4E5

CANADA

 

Page 1 of 3


 

 

 

 

DIRECTOR INFORMATION

 

Last Name, First Name, Middle Name:

Glickman, Richard M.

 

Mailing Address:

[***]

 

Delivery Address:

[***]

 

Last Name, First Name, Middle Name:

Cooper, Ronald

 

 

 

Mailing Address:

[***]

 

Delivery Address:

[***]

 

Last Name, First Name, Middle Name:

Heffernan, Michael

 

 

Mailing Address:

4868 RUE LEVY

SUITE 220

SAINT-LAURENT QC H4R 2P1

CANADA

 

Delivery Address:

4868 RUE LEVY

SUITE 220

SAINT-LAURENT QC H4R 2P1

CANADA

 

Last Name, First Name, Middle Name:

Zoth, Lota

 

 

Mailing Address:

[***]

 

Delivery Address:

[***]

 

Last Name, First Name, Middle Name:

Astley-Sparke, Philip

 

 

Mailing Address:

4868 RUE LEVY

SUITE 220

SAINT-LAURENT QC H4R 2P1

CANADA

 

Delivery Address:

4868 RUE LEVY

SUITE 220

SAINT-LAURENT QC H4R 2P1

CANADA

 

Last Name, First Name, Middle Name:

Brunk, Gerald

 

 

Mailing Address:

[***]

 

Delivery Address:

[***]

 

 

Page 2 of 3


 

 

Last Name, First Name, Middle Name:

Joustra, Wouter

 

 

Mailing Address:

[***]

 

Delivery Address:

[***]

 

Last Name, First Name, Middle Name:

Grossman, William

 

 

 

Mailing Address:

4868 RUE LEVY

SUITE 220

SAINT-LAURENT QC H4R 2P1

CANADA

 

Delivery Address:

4868 RUE LEVY

SUITE 220

SAINT-LAURENT QC H4R 2P1

CANADA

 

Last Name, First Name, Middle Name:

Hastings, Paul

 

 

Mailing Address:

[***]

Delivery Address:

[***]

 

 

 

 

 

AUTHORIZED SHARE STRUCTURE

 

 

 

 

 

 

1.

No Maximum

Common Shares

Without Par Value

 

 

 

 

 

 

 

 

 

With Special Rights or

Restrictions attached

 

 

 

 

 

 

 

 

 

 

 

2.

No Maximum

Preferred Shares

Without Par Value

 

 

 

 

 

 

 

 

 

With Special Rights or

Restrictions attached

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Page 3 of 3


 

 

img197432392_2.jpg

Number: C1447134

 

 

CERTIFICATE

OF

CHANGE OF NAME

 

BUSINESS CORPORATIONS ACT

 

 

 

 

 

I Hereby Certify that ENGENE HOLDINGS INC. changed its name to ENGENE
THERAPEUTICS INC. on April 8, 2026 at 12:01 AM Pacific Time.

 

 

 

 

 

 

 

 

img197432392_3.jpg

Issued under my hand at Victoria, British Columbia

On April 8, 2026

 

img197432392_4.jpg

 

KERRY TAYLOR

Registrar of Companies

Province of British Columbia

Canada

 

ELECTRONIC CERTIFICATE

 

 

 


Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer